AstraZeneca sale haunts SA in third wave, but Kubayi stands by ...

News

Vaccine updates

AstraZeneca sale haunts SA in third wave, but Kubayi stands by decision

It is more than 90% effective against hospitalisation from Delta variant which is ‘likely to blame’ for third wave

Senior science reporter

It was a contentious sale that haunts the country.

In mid-March the government sold about a million doses of the AstraZeneca (AZ) vaccine to other African nations after it emerged that its efficacy was substantially reduced by the Beta variant.

Now that the Delta variant is surging through SA, the AZ decision has reared its head again because an analysis by Public Health England (PHE) showed it offered protection of more than 90% against hospitalisation from the variant...

This article is free to read if you register or sign in.

Sunday Times Daily

If you have already registered or subscribed, please sign in to continue.

Questions or problems?
Email helpdesk@timeslive.co.za or call 0860 52 52 00.